<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00282685</url>
  </required_header>
  <id_info>
    <org_study_id>2005-000969-19</org_study_id>
    <secondary_id>RENERVATE</secondary_id>
    <nct_id>NCT00282685</nct_id>
  </id_info>
  <brief_title>Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy</brief_title>
  <official_title>(Restoration of Nerve Functions by Intra-Arterial Transplantation of Bone Marrow Progenitor Cells in Patients With Diabetic Poly Neuropathy (PNP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of patients with diabetic neuropathy by intraarterial progenitor cell
      transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Goal is:

      Stimulation of angiogenesis and induction of vasa nervorum in order to improve nerve function
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2005</start_date>
  <completion_date type="Anticipated">October 2008</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of neurological score: modified NIS(LL)+7</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Toronto Clinical Scoring System</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diabetic Neuropathies</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraarterial bone marrow progenitor cell transplantation</intervention_name>
    <description>catheter delivery of stem cells</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with distal symmetrical diabetic neuropathy of the legs

          -  Type 1 or Type 2 Diabetes

          -  Stable Glucose control over last 3 months (Hba1c &lt;7.5)

          -  Written informed consent

        Exclusion Criteria:

          -  Patients with peripheral arterial disease (ABI &lt;0.9)

          -  Neuropathy of other origin

          -  Myopathy

          -  Asymmetrical neuropathy

          -  Active infection oder fever

          -  Chronic inflammatory disease (z.B M. Crohn, Rheumatoid Arthritis)

          -  HIV or hepatitis

          -  Neoplastic disease without complete remission within last 5 y

          -  Stroke or myocardial infarction within last 3 months

          -  Renal failure (creatinine &gt; 2 mg/dl)

          -  Liver disease (GOT &gt; 2 upper limit or spontaneous INR &gt; 1,5).

          -  Anemia (hemoglobine &lt; 8.5 mg/dl)

          -  Platelets &lt;100.000/Âµl

          -  HbA1c &gt;7,5 %

          -  Allergies to Aspirin, Clopidogrel, Heparin

          -  Bleeding disorder

          -  Surgery or trauma within the last 2 months

          -  Pregnancy

          -  Mental retardation

          -  Participation in another study within 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas M Zeiher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Div. of Cardiology, University of Frankfurt, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dirk H Walter, MD</last_name>
    <role>Study Director</role>
    <affiliation>Div. of Cardiology, University of Frankfurt, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dirk H Walter, MD</last_name>
    <phone>+49 69 6301</phone>
    <phone_ext>5932</phone_ext>
    <email>d.walter@em.uni-frankfurt.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Div. of Cardiology and Vascular Medicine</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk H Walter, MD</last_name>
      <phone>+49 69 6301</phone>
      <phone_ext>5932</phone_ext>
      <email>d.walter@em.uni-frankfurt.de</email>
    </contact>
    <contact_backup>
      <last_name>Andreas M Zeiher, MD</last_name>
      <phone>+49 69 6301</phone>
      <phone_ext>5789</phone_ext>
      <email>zeiher@em.uni-frankfurt.de</email>
    </contact_backup>
    <investigator>
      <last_name>Andreas M Zeiher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dirk H Walter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2006</study_first_submitted>
  <study_first_submitted_qc>January 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2006</study_first_posted>
  <last_update_submitted>November 21, 2007</last_update_submitted>
  <last_update_submitted_qc>November 21, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2007</last_update_posted>
  <keyword>Patients with symmetric peripheral diabetic neuropathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

